Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Eugene W. Monroe"'
Autor:
Eugene W. Monroe
Publikováno v:
International Journal of Dermatology. 35:837-841
Autor:
Eugene W. Monroe
Publikováno v:
Current Problems in Dermatology. 5:118-140
Autor:
Eugene W. Monroe
Publikováno v:
Journal of Allergy and Clinical Immunology. 86:662-665
For many years, H 1 , antihistamines have been the primary management option for urticaria. However, undesirable side effects, particularly daytime sedation, have limited the usefulness of these classic antihistamines. A new class of peripherally act
Autor:
Albert Finn, Eugene W. Monroe, Piyush M. Patel, Paul H. Ratner, Robinson Guerrero, David I. Bernstein
Publikováno v:
Journal of the American Academy of Dermatology. 48(4)
Background: Chronic idiopathic urticaria (CIU) has a major impact on patient well-being. Antihistamines are the first-line treatment for CIU; however, some cause sedation. Objective: Our purpose was to study the efficacy and safety of desloratadine,
Publikováno v:
Journal of the American Academy of Dermatology. 44
In two randomized, double-blind, multicenter studies, a total of 631 adult patients with moderate to severe atopic dermatitis applied tacrolimus ointment (0.03% or 0.1%) or vehicle twice daily for up to 12 weeks. The mean percent body surface area (%
Autor:
Daniel Stewart, Dennis E. Babel, Bruce H. Thiers, Ann G. Martin, Louis Falo, Marvin R. Young, Mark Lebwohl, Mark Ling, Lynn A. Drake, H.Irving Katz, James Kalivas, Joel Cook, Vincent Falanga, Sewon Kang, James J. Leyden, Jon M. Hanifin, Robert J. Pariser, Michael Jarratt, David M. Pariser, Leonard J. Swinyer, Jennie Muglia, Gerald D. Weinstein, Charles McDonald, Eugene W. Monroe, Michael D. Tharp, Richard G. Asarch, Wilma F. Bergfeld, Bernard S. Goffe, William H. Eaglstein
Publikováno v:
Journal of the American Academy of Dermatology. 38(6 Pt 2)
Background: Fluconazole is a bis -triazole antifungal agent approved for the treatment of oropharyngeal, esophageal, and vaginal candidiasis, serious systemic candidal infections, and cryptococcal meningitis. Objective: The purpose of this study was
Autor:
Eugene W. Monroe, Renie Bressinck, Roger C. Cornell, Daniel J. Tanner, Debra L. Breneman, Richard L. DeVillez, Libby Edwards, Daniel Piacquadio, Cynthia Guzzo, John Koo, Cynthia A. Cuffie
Publikováno v:
Clinical therapeutics. 20(2)
Topical corticosteroids and keratolytics are both used widely in the management of patients with psoriasis. A combination of the two types of agents may provide enhanced relief. The purpose of this study was to compare the efficacy and safety of the
Autor:
Eugene W. Monroe
Publikováno v:
Clinical therapeutics. 19(2)
Urticaria is a common skin disease, which in its chronic form, is a very disturbing condition. Because histamine is the best-documented chemical mediator of urticaria, histamine-antagonists are the mainstay of therapy. First-generation antihistamines
Publikováno v:
The Journal of allergy and clinical immunology. 99(2)
Antihistaminic drugs have been used successfully for many years in the treatment of allergic diseases. Second-generation antihistamines have fewer sedating side effects than first-generation agents, and the number of newer drugs available for clinica
Autor:
Eugene W. Monroe
Publikováno v:
Journal of Allergy and Clinical Immunology. 102:333-334